US Patent Issued to Bayer HealthCare on May 13 for "Oral bilayer tablets comprising acetylsalicylic acid and pseudoephedrine, methods of preparing and using thereof" (New Jersey Inventor)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,296,051, issued on May 13, was assigned to Bayer HealthCare LLC (Whippany, N.J.).

"Oral bilayer tablets comprising acetylsalicylic acid and pseudoephedrine, methods of preparing and using thereof" was invented by Harsh Mehta (Randolph, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates generally to bilayer tablets comprising a combination of two active pharmaceutical ingredients, and more specifically to bilayer tablets comprising acetylsalicylic acid, pseudoephedrine, and a dissolution aid. The bilayer tablets utilize a combination of granulated and non-granulated acetylsalicylic acid along with a unique distribution of ...